142 related articles for article (PubMed ID: 35840716)
1. Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases.
Hussain RN; Chiu A; Pittam B; Taktak A; Damato BE; Kacperek A; Errington D; Cauchi P; Chadha V; Connolly J; Salvi S; Rundle P; Cohen V; Arora A; Sagoo M; Bekir O; Kopsidas K; Heimann H
Eye (Lond); 2023 Apr; 37(5):1033-1036. PubMed ID: 35840716
[TBL] [Abstract][Full Text] [Related]
2. [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].
Gambrelle J; Kodjikian L; Rouberol F; Donate D; Duquesne N; Jean-Louis B; Chauvel P; Gérard JP; Romestaing P; Grange JD
J Fr Ophtalmol; 2004 Jan; 27(1):40-7. PubMed ID: 14968076
[TBL] [Abstract][Full Text] [Related]
3. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
5. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
6. Intraocular collision tumour: case report and literature review.
Coupland SE; Dodson A; Liu H; Du MQ; Angi M; Damato BE
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1383-8. PubMed ID: 23232651
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
8. Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma.
van Beek JGM; Ramdas WD; Angi M; van Rij CM; Naus NC; Kacperek A; Errington RD; Damato B; Heimann H; Kiliç E
Radiother Oncol; 2021 Apr; 157():219-224. PubMed ID: 33549643
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project).
Spatola C; Privitera G; Raffaele L; Salamone V; Cuttone G; Cirrone P; Sabini MG; Lo Nigro S
Tumori; 2003; 89(5):502-9. PubMed ID: 14870772
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
13. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
14. Posterior uveal melanoma in young patients treated with proton beam therapy.
Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
[TBL] [Abstract][Full Text] [Related]
15. Quantitative echography in primary uveal melanoma treated by proton beam therapy.
Mosci C; Lanza FB; Mosci S; Barla A
Can J Ophthalmol; 2014 Feb; 49(1):60-5. PubMed ID: 24513359
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
17. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
18. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach.
Angi M; Kalirai H; Taktak A; Hussain R; Groenewald C; Damato BE; Heimann H; Coupland SE
Br J Ophthalmol; 2017 Aug; 101(8):1143-1146. PubMed ID: 28596284
[TBL] [Abstract][Full Text] [Related]
19. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
20. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
